Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Abeona Therapeutics (ABEO) over the last 13 years, with Sep 2025 value amounting to 0.01.

  • Abeona Therapeutics' Asset Utilization Ratio rose 3.90% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 3.90%. This contributed to the annual value of 0.00 for FY2024, which is 99.20% down from last year.
  • As of Q3 2025, Abeona Therapeutics' Asset Utilization Ratio stood at 0.01, which was up 39.33% from 0.00 recorded in Q2 2025.
  • Abeona Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.08 during Q4 2023, with a 5-year trough of -0.04 in Q4 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.03, with a median of 0.01 in 2024.
  • Data for Abeona Therapeutics' Asset Utilization Ratio shows a peak YoY increase of 1,048.30% (in 2021) and a maximum YoY decrease of 166.26% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Asset Utilization Ratio stood at -0.04 in 2021, then skyrocketed by 170.34% to 0.03 in 2022, then soared by 190.96% to 0.08 in 2023, then crashed by 99.56% to 0.00 in 2024, then increased by 3.90% to 0.01 in 2025.
  • Its Asset Utilization Ratio was 0.01 in Q3 2025, compared to 0.00 in Q2 2025 and 0.00 in Q1 2025.